Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,HR[95%CI],P_value
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter I Certain infectious and parasitic diseases,"Bacterial infection, other or unspecified",41642,226,1.03 [0.73-1.45],0.8853495479964295
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",43076,323,0.96 [0.71-1.30],0.806371777820759
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",42641,2260,0.96 [0.86-1.07],0.4649490217021453
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter I Certain infectious and parasitic diseases,Candidiasis,43107,697,1.14 [0.95-1.37],0.1480724882827694
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,41796,5745,0.97 [0.90-1.04],0.3683325049366486
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),42001,5230,1.03 [0.96-1.11],0.433900852929731
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter I Certain infectious and parasitic diseases,Diarrhoea and gastroenteritis of presumed infectious origin,42697,1995,0.94 [0.83-1.06],0.3397258117822045
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter I Certain infectious and parasitic diseases,Enterocolitis due to Clostridium difficile,42960,142,0.78 [0.47-1.29],0.3309686403129472
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,39755,1551,0.93 [0.81-1.07],0.3257136649795801
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,38386,1738,1.01 [0.89-1.14],0.8830423754259771
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter I Certain infectious and parasitic diseases,Implicit fungal Sepsis,38247,406,1.01 [0.78-1.31],0.918121339514686
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,30235,3204,1.02 [0.93-1.12],0.6180731943092146
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,38007,641,1.16 [0.96-1.40],0.1340547141474482
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,43048,2346,0.98 [0.88-1.09],0.7100008918409637
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter I Certain infectious and parasitic diseases,Mycoses,43230,820,1.14 [0.96-1.35],0.1326813527139289
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,41890,1509,0.93 [0.80-1.07],0.2867168782222217
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,43123,1707,0.97 [0.85-1.11],0.6581636089299101
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,41027,325,0.95 [0.70-1.29],0.7483479838957716
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter I Certain infectious and parasitic diseases,Other infectious diseases,43321,77,1.04 [0.57-1.87],0.9089524474539818
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter I Certain infectious and parasitic diseases,Other septicaemia,42913,1497,0.92 [0.80-1.07],0.2831528056142662
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,42943,125,1.11 [0.72-1.73],0.6374500149914488
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter I Certain infectious and parasitic diseases,Other viral diseases,43180,260,1.21 [0.91-1.62],0.1850182526733035
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",43152,232,1.13 [0.82-1.55],0.46803321861357
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,41053,672,0.97 [0.78-1.19],0.7397829286292184
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter I Certain infectious and parasitic diseases,Viral agents as the cause of diseases classified to other chapters,40838,457,1.09 [0.86-1.38],0.4729388375835532
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter I Certain infectious and parasitic diseases,Viral and other specified intestinal infections,40871,169,1.24 [0.88-1.76],0.2179673730791582
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter I Certain infectious and parasitic diseases,Viral hepatitis,43280,88,1.00 [0.57-1.77],0.989688832308498
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,43206,263,0.92 [0.65-1.29],0.6160649437910423
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter I Certain infectious and parasitic diseases,Viral warts,43028,85,1.00 [0.57-1.76],0.9883475714657216
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter I Certain infectious and parasitic diseases,Zoster [herpes zoster],43058,115,0.85 [0.50-1.44],0.547029268774335
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,Benign lipomatous neoplasm,42819,489,1.12 [0.90-1.40],0.2958014377217943
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,43171,98,1.34 [0.88-2.05],0.1749577733473108
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,43132,107,0.64 [0.35-1.19],0.1597249728240781
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,Benign lipomatous neoplasm of spermatic cord,19825,107,1.24 [0.80-1.91],0.3388072017853484
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",42757,2391,1.05 [0.94-1.16],0.3695736089588567
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,Benign neoplasm of meninges,43296,99,1.12 [0.69-1.81],0.6589947279487469
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,43213,114,1.08 [0.68-1.73],0.746369979529933
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,Benign neoplasm of other and unspecified endocrine glands,43278,179,1.11 [0.77-1.61],0.5615896033929786
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,Benign neoplasm of ovary,23387,148,1.20 [0.83-1.74],0.3408386153684939
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,Benign neoplasm: Ascending colon,43279,610,1.13 [0.92-1.37],0.2406059800728087
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,Benign neoplasm: Caecum,43288,499,1.24 [1.01-1.51],0.0382538929791857
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",43132,118,1.35 [0.91-2.00],0.1297460405758809
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,Benign neoplasm: Descending colon,43282,371,0.91 [0.68-1.21],0.5143943468647364
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,Benign neoplasm: Rectum,43206,584,0.85 [0.67-1.08],0.1893208537116627
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,43118,1044,1.07 [0.91-1.25],0.4050225046723097
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,Benign neoplasm: Transverse colon,43272,704,1.22 [1.03-1.45],0.023865303852369
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,Carcinoma in situ of breast,19003,118,0.78 [0.46-1.33],0.3618620254905939
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",19073,136,0.84 [0.51-1.35],0.4652808590533823
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",34555,92,0.31 [0.15-0.66],0.0024395385817045
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,"Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)",34577,114,0.90 [0.54-1.51],0.6900982962308689
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",43233,202,1.23 [0.89-1.68],0.2053473517200673
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,"Haemangioma, any site",43234,197,1.24 [0.91-1.71],0.1787556141524372
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,Leiomyoma of uterus,22605,487,1.22 [0.99-1.50],0.0564139575730527
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,Lung cancer and mesothelioma,30092,568,1.00 [0.77-1.29],0.9869223472220492
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,Lymphoid leukaemia,34552,89,0.71 [0.38-1.36],0.3049661792284963
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",34776,313,0.92 [0.67-1.24],0.5754843510111742
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",34795,332,0.89 [0.66-1.21],0.4604390617842466
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",19204,165,1.07 [0.73-1.58],0.7240687595683827
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",34599,136,0.87 [0.53-1.41],0.5672224924014639
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,"Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)",34630,167,0.99 [0.66-1.49],0.9638145822497824
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,"Malignant neoplasm of oesophagus, excluding all cancers (controls excluding all cancers)",34633,170,1.18 [0.82-1.70],0.3636750765416418
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",19161,122,1.29 [0.87-1.91],0.206867260196155
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,"Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)",34622,159,0.99 [0.65-1.51],0.9744479674520548
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",16567,1143,0.85 [0.72-1.01],0.0665761661806171
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,"Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)",34661,198,1.15 [0.82-1.61],0.4295158661574925
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,"Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)",34586,123,1.12 [0.72-1.74],0.6273066127885495
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,34635,172,1.08 [0.74-1.57],0.7038273449982715
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,Melanocytic naevi,42996,349,0.88 [0.65-1.18],0.3920277669380985
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,Melanocytic naevi of trunk,43259,154,0.69 [0.42-1.14],0.1498801181199495
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,Melanoma in situ,34518,137,0.71 [0.43-1.20],0.2043895689175116
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,"Non-follicular lymphoma, hilmo, excluding all cancers",34617,154,0.81 [0.51-1.29],0.378852793359597
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",34731,268,0.80 [0.56-1.15],0.2281745860584835
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",34856,393,1.02 [0.78-1.34],0.8894554828785615
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",34629,166,0.76 [0.48-1.21],0.245241323592348
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,Other benign neoplasms of skin,43017,272,1.17 [0.88-1.56],0.2807257023390017
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",36238,1775,0.92 [0.81-1.05],0.2196982604320994
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",36334,1871,0.95 [0.84-1.07],0.4102503893256743
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,42820,573,0.95 [0.76-1.19],0.6419476011809437
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Anaemia in chronic diseases classified elsewhere,40220,146,1.45 [1.05-2.00],0.0256576992951744
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of spleen,42372,125,0.87 [0.52-1.44],0.5857758513581163
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,42023,4768,0.98 [0.91-1.06],0.5814388485668776
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Folate deficiency anaemia,40940,78,1.25 [0.75-2.08],0.3920187120431991
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Idiopathic thrombocytopenic purpura,42632,85,1.05 [0.61-1.83],0.8495990476263363
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,42546,2472,1.02 [0.92-1.14],0.661779337125642
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,42544,2470,1.02 [0.92-1.14],0.665930843693584
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified aplastic anaemias,40217,143,1.21 [0.83-1.78],0.3274739858962175
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,42786,1924,1.03 [0.91-1.16],0.6387609244713126
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other coagulation defects,42737,190,1.20 [0.86-1.68],0.2809081146318667
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other diseases of blood and blood-forming organs,42350,103,1.35 [0.89-2.06],0.1571087402428388
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other disorders of white blood cells,42354,107,0.59 [0.32-1.11],0.1044418423341202
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Purpura and other haemorrhagic conditions,42998,451,1.07 [0.84-1.35],0.5927354968657457
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Sarcoidosis,43145,91,0.97 [0.55-1.69],0.9115555513469068
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,"Thrombocytopenia, unspecified",42922,375,1.16 [0.90-1.48],0.2475164940415014
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Vitamin B12 deficiency anaemia,41033,171,0.66 [0.40-1.06],0.0877932785302058
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Acidosis,33618,504,0.95 [0.75-1.21],0.6896903960381611
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Acute alcohol intoxication,40395,191,0.98 [0.67-1.44],0.9237839095860668
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Alcohol dependence,40415,211,1.12 [0.79-1.59],0.5153363640077722
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Alkalosis,33205,91,1.70 [1.21-2.40],0.002240076039738
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Bipolar affective disorders,40273,106,0.51 [0.26-0.99],0.0451141498511035
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Deficiency of other B group vitamins,39354,387,0.91 [0.68-1.20],0.5016916399211614
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Delirium, not induced by alcohol and other psychoactive substances",42568,876,0.88 [0.73-1.07],0.1999403966472308
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in Alzheimer disease,42136,444,0.87 [0.67-1.14],0.3186343387432499
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in other diseases classified elsewhere,41864,172,0.92 [0.61-1.40],0.7055642814278316
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression,42747,2580,0.95 [0.85-1.06],0.3375895237808043
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression or dysthymia,37829,2511,0.96 [0.86-1.07],0.4730751871432627
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of lipoprotein metabolism, unspecified",33222,108,1.00 [0.61-1.66],0.9873149021104878
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of thyroid, unspecified",40025,137,1.07 [0.70-1.64],0.7420103217251076
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of calcium metabolism,33575,461,0.92 [0.71-1.19],0.5444047627767391
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of iron metabolism,33216,102,0.89 [0.51-1.54],0.6691351655285898
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,38997,5883,1.00 [0.93-1.07],0.9937721467926935
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of magnesium metabolism,33447,333,1.14 [0.88-1.49],0.313039509536014
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,34041,927,1.02 [0.86-1.21],0.7946090413822562
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,43193,524,1.08 [0.87-1.35],0.489674172944669
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of parathyroid gland,42878,209,1.25 [0.92-1.70],0.155701490100356
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of phosphorus metabolism and phosphatases,33327,213,1.07 [0.76-1.51],0.6914869496093441
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorders of plasma-protein metabolism, not elsewhere classified",33216,102,1.26 [0.81-1.93],0.3034726160201642
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,42423,2535,1.00 [0.91-1.11],0.9311320543807844
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Fluid overload,33521,407,0.97 [0.74-1.27],0.834635975664406
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperkalaemia,33560,446,0.96 [0.74-1.24],0.7668571619637423
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",34167,1053,1.02 [0.87-1.20],0.8114013416640388
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,33295,181,1.13 [0.79-1.62],0.5162653626941491
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,42867,198,1.18 [0.85-1.65],0.3296388221050724
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypo-osmolality and hyponatraemia,34115,1001,1.13 [0.97-1.31],0.1247657081468963
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypokalaemia,33912,798,0.97 [0.81-1.18],0.7842615663805541
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Iron deficiency,39074,107,0.89 [0.52-1.53],0.684785859878599
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,41424,8310,1.01 [0.96-1.07],0.6662883490712564
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic multinodular goitre,39961,73,0.78 [0.39-1.57],0.4915802426764758
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic single thyroid nodule,39985,97,1.10 [0.67-1.81],0.6949482634296538
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,43022,3209,1.05 [0.96-1.15],0.3109578314484445
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",43022,3203,1.05 [0.96-1.16],0.2849176487463186
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other and/or unspecified nontoxic goitre,39970,82,0.90 [0.49-1.66],0.746012576041668
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other anxiety disorders,42743,2022,0.94 [0.83-1.06],0.2809394482809493
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",35700,2586,1.02 [0.93-1.14],0.637038631113269
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other disorders of glucose regulation and pancreatic internal secretion,43304,347,1.00 [0.75-1.33],0.9968315500372186
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,41815,123,0.84 [0.50-1.41],0.5066119210975938
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Panic disorder,40898,177,0.92 [0.61-1.39],0.7051426763886816
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Phobic anxiety disorders,40963,242,1.02 [0.73-1.42],0.8973733893543918
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",33382,268,1.07 [0.79-1.45],0.6520942500050486
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,39436,255,1.01 [0.72-1.40],0.9622447690776548
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,3553,138,1.41 [0.96-2.05],0.077144495572461
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,3783,414,1.27 [0.99-1.63],0.0581213030154578
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,39283,102,0.80 [0.44-1.43],0.4446700699444867
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,3492,78,1.17 [0.64-2.13],0.60565182806875
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,42287,3106,0.99 [0.90-1.09],0.909315847220448
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Unspecified dementia,42243,551,1.12 [0.91-1.37],0.2939572771396557
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Vitamin D deficiency,39574,607,1.00 [0.81-1.23],0.988289306356115
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,34339,1225,1.06 [0.92-1.23],0.4044071527335419
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",43126,407,1.13 [0.89-1.44],0.3224413771482802
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Abdominal aortic aneurysm (AAA),41441,276,1.21 [0.90-1.62],0.2042393425601507
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Angina pectoris,39633,1952,1.03 [0.92-1.16],0.6029921446841742
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Aortic aneurysm,41572,407,0.99 [0.75-1.29],0.9221806301745872
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Arterial embolism and thrombosis of lower extremity artery,41260,95,1.61 [1.10-2.36],0.0142394908127028
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,"Atherosclerosis, excluding cerebral and coronary sclerosis",41491,326,1.28 [0.99-1.65],0.0554681386866746
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,26873,3107,0.97 [0.88-1.06],0.462770639896132
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,AV-block,36646,703,0.90 [0.73-1.10],0.2958677624007212
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",43220,689,1.00 [0.82-1.22],0.9816757448779072
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Cardiac arrest,24077,311,0.81 [0.58-1.12],0.1948075303879313
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Cardiomyopathy,36228,285,0.87 [0.62-1.21],0.3986135277369891
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,"Cardiomyopathy, other and unspecified",36104,161,1.13 [0.77-1.65],0.5400895457945477
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Cerebral atherosclerosis,43319,74,1.17 [0.68-2.04],0.5675608464725885
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Conduction disorders,37673,1730,1.03 [0.92-1.17],0.585954766879944
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,41082,3429,1.02 [0.94-1.12],0.6144309839993105
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,37920,12700,0.99 [0.94-1.03],0.6018969533894787
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,DVT of lower extremities,41027,439,1.12 [0.88-1.41],0.3605300544701731
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Endocarditis,36058,115,0.78 [0.45-1.35],0.3814273941537285
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,"Heart failure, strict",42976,1787,1.02 [0.91-1.16],0.6994917916376044
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Hypertension,39439,10868,0.99 [0.94-1.04],0.5846092666144183
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,"Hypertension, essential",39453,10882,0.99 [0.94-1.04],0.6244514603347403
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,"Hypertension, portal",43034,131,1.27 [0.86-1.89],0.227773648253013
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",28883,312,1.05 [0.79-1.39],0.7259828649230349
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,28728,157,0.77 [0.48-1.23],0.2717376941360931
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Hypotension,43087,1878,1.03 [0.91-1.16],0.6190975305527644
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Intracerebral haemorrhage,41818,176,1.09 [0.74-1.59],0.6679757857693654
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",41366,3685,1.02 [0.93-1.11],0.6831943512841663
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",42720,921,1.11 [0.95-1.31],0.1950133745140493
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Left bundle-branch block,36547,604,1.21 [1.01-1.45],0.0400491193890286
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,42549,1402,0.98 [0.85-1.13],0.804023814156419
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",38862,1181,0.99 [0.85-1.16],0.8929376060686409
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",43161,263,0.98 [0.70-1.37],0.9070044418536212
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, without ST-elevation",43270,525,1.08 [0.86-1.34],0.5165254618731523
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Oesophageal varices,40677,89,1.16 [0.69-1.95],0.5686464600503947
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Other aneurysm,41286,121,0.95 [0.58-1.56],0.8345510459942034
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Other arrhythmias,36651,708,1.04 [0.86-1.26],0.6725415394737115
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Other arterial embolism and thrombosis,41333,168,1.40 [1.01-1.94],0.0453825434884515
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,41563,398,1.36 [1.10-1.68],0.0049058659275961
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Other diseases of pericardium,36239,296,1.02 [0.75-1.37],0.9202533894616156
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Other disorders of veins,40735,147,1.35 [0.95-1.92],0.093083340391592
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Other embolism and thrombosis,40670,82,0.91 [0.49-1.70],0.774216973994365
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Other intracranial haemorrhages,40973,107,0.86 [0.50-1.50],0.6043974204054856
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Other noninfective disorders of lymphatic vessels and lymph nodes,40804,216,1.28 [0.94-1.74],0.1182177234093122
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,37626,1683,1.03 [0.91-1.17],0.6236554055432787
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Other other unspecified disorders of the circulatory system,41299,90,0.99 [0.56-1.73],0.9603674806127118
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,42061,896,1.20 [1.03-1.41],0.0207794089826961
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,42286,585,1.00 [0.80-1.24],0.9802271434706956
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,"Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere",41859,993,1.11 [0.95-1.29],0.2052306767748137
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,24319,553,1.04 [0.84-1.28],0.7280222505988998
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Peripheral artery disease,41773,658,1.08 [0.88-1.32],0.4531911426577137
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),41157,569,1.12 [0.91-1.38],0.2771112691134967
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Pulmonary embolism,42484,783,1.06 [0.88-1.27],0.5281148147505893
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,43199,1067,1.16 [1.00-1.34],0.0523313033914238
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Right bundle-branch block,36517,574,1.01 [0.81-1.25],0.9576632340657876
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Secondary right heart disease,42279,578,1.02 [0.82-1.27],0.8659541983375273
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Sequelae of cerebrovascular disease,41175,309,1.06 [0.79-1.41],0.7117028701051897
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",42698,1056,1.08 [0.92-1.26],0.359579859765411
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",42665,1121,1.06 [0.91-1.24],0.4328605689772343
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Subarachnoid haemorrhage,41776,100,0.88 [0.50-1.55],0.6653375850778168
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Thoracic aortic aneurysm,41296,132,1.12 [0.73-1.72],0.6160061757314552
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Transient ischemic attack,42170,371,1.25 [0.99-1.58],0.0593293628735006
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,41578,431,0.89 [0.68-1.17],0.4128734149084597
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Varicose veins,41274,686,1.14 [0.95-1.37],0.1720658805083832
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Vascular diseases of the intestine,41191,143,1.18 [0.79-1.75],0.4253456621658888
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Venous thromboembolism,42928,1232,1.09 [0.94-1.25],0.258572951305658
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",43112,597,1.17 [0.96-1.43],0.1183882806251415
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",37982,2390,0.93 [0.83-1.04],0.2171350920748586
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter V Mental and behavioural disorders,Any mental disorder,42235,6643,0.97 [0.91-1.04],0.3759421662684541
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",43033,698,1.14 [0.95-1.38],0.1609177077699501
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",38223,2631,0.94 [0.85-1.05],0.2633135791690099
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",35733,141,1.05 [0.69-1.59],0.8285986491418261
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter V Mental and behavioural disorders,Smoking dependency,42422,2302,1.09 [0.99-1.21],0.0921639457624759
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",38317,2725,1.05 [0.95-1.16],0.3209680201336433
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter V Mental and behavioural disorders,Vascular dementia,42529,209,0.87 [0.59-1.29],0.4990633466363251
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,Alzheimer disease,43319,555,0.97 [0.78-1.22],0.8055300079535705
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,"Alzheimer√ïs disease (Atypical or mixed), excluding more controls",29374,97,0.77 [0.42-1.41],0.3970842352289253
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,Bell's palsy,40356,139,1.27 [0.87-1.85],0.2118356404671357
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,41045,828,0.95 [0.78-1.14],0.564521686833815
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,Cerebral cysts,42645,382,1.06 [0.82-1.38],0.6493744836856605
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,43183,504,1.03 [0.82-1.29],0.8179271705873785
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,Circumscribed brain atrophy,42509,91,1.17 [0.72-1.91],0.5256776428507719
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,Diseases of the myoneural junction and muscle,43293,109,1.27 [0.83-1.94],0.2671576704736851
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,"Disorders of brain, other and unspecified",42384,121,1.47 [1.04-2.08],0.0296845065229657
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,Epilepsy,40751,464,0.94 [0.73-1.21],0.6456678957436263
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,42523,2236,1.08 [0.97-1.20],0.1632115001439742
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,Extrapyramidal and movement disorders,43244,692,0.85 [0.69-1.06],0.1427808657385812
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,Falls/tendency to fall,42329,4209,1.05 [0.97-1.14],0.1858541179921895
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,Generalized epilepsy,42698,88,1.22 [0.75-1.99],0.430020342568846
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,Hemiplegia,43075,396,1.03 [0.79-1.34],0.8290838960783913
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,Hydrocephalus,42367,104,1.02 [0.61-1.70],0.9315504136810248
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,Inflammatory diseases of the central nervous system,43286,116,1.02 [0.63-1.66],0.9202626406241404
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,Lesion of plantar nerve,40343,126,1.09 [0.71-1.69],0.69334790225525
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,Lesion of ulnar nerve,40351,134,0.95 [0.59-1.52],0.8207909911230371
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,Memory loss,42288,194,1.06 [0.74-1.52],0.750040283901222
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,Migraine,40881,594,1.05 [0.85-1.29],0.6521512898989069
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",43203,539,0.94 [0.75-1.19],0.6294582461923544
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,Motor neuron disease,29562,249,1.15 [0.85-1.55],0.3536053463050611
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,43029,178,1.19 [0.83-1.70],0.3407043291493525
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",42208,1991,0.97 [0.86-1.09],0.5683713007874098
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,Neurological diseases,40832,6070,0.99 [0.93-1.06],0.7768315268856113
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,Other and unspecified degenerative diseases of nervous system,42721,303,0.93 [0.68-1.27],0.6622972484063396
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",40882,665,0.95 [0.78-1.18],0.6649470687843764
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,"Other and unspecified polyneuropathies, also in other diseases",43198,483,1.12 [0.90-1.41],0.3072369005435791
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,34668,1062,1.01 [0.86-1.18],0.9203780710193564
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,Other diseases of spinal cord,42383,120,0.85 [0.50-1.43],0.5371860368146165
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,Other disorders of nervous system,42494,231,1.19 [0.88-1.62],0.2643082086796023
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,Other extrapyramidal and movement disorders in other diseases,42800,248,0.74 [0.50-1.08],0.1186094212380033
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,Other facial nerve disorders,40381,164,1.15 [0.79-1.67],0.4536390478338976
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,Other headache syndromes,40389,102,1.00 [0.59-1.67],0.98613599434176
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,Other neurological diseases,43120,857,1.09 [0.92-1.30],0.2974014338952958
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,Other sleep disorders,41201,914,1.07 [0.90-1.27],0.4219705085235495
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,Parkinson's disease,43276,405,0.91 [0.69-1.20],0.5031520309211772
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,Postviral fatigue syndrome,42356,93,1.24 [0.78-1.96],0.3570790210404521
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,Restless leg syndrome,43317,110,0.58 [0.31-1.08],0.0837907409457938
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,Sleep apnoea,42928,796,1.19 [1.00-1.41],0.0499577135977225
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,Small fibre neuropathy,42795,80,0.90 [0.49-1.68],0.7475010217123117
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,43292,293,1.12 [0.85-1.49],0.4243079396478098
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,Trigeminal neuralgia,40302,85,0.63 [0.31-1.26],0.1889163930176782
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,Unspecific neurodegenerative disorder,43319,561,0.96 [0.77-1.21],0.7434059680895402
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,Vascular dementia (undefined),42463,202,0.89 [0.60-1.32],0.5555462179301867
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Amblyopia ex anopsia,42364,160,0.73 [0.45-1.18],0.1943551491484004
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Astigmatism,42642,663,1.14 [0.95-1.37],0.157506583434233
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,43045,387,0.99 [0.75-1.30],0.942549827806789
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Blepharochalasis,41634,85,1.14 [0.67-1.92],0.6307666320737195
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,41648,99,1.22 [0.76-1.94],0.4092225766914119
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Conjunctivitis (acute, non atopic)",43134,90,0.59 [0.30-1.18],0.1340888058615087
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Corneal degeneration,42890,250,0.73 [0.50-1.07],0.1067143660521246
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",3499,84,1.25 [0.72-2.18],0.4224179395267161
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic neuropathy,4238,160,1.26 [0.87-1.82],0.21310865951971
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diplopia,42368,164,1.00 [0.67-1.51],0.9938037368491768
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,42980,1721,1.08 [0.96-1.22],0.1817976454165705
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",42694,1145,1.12 [0.97-1.29],0.124185584094494
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,41922,373,1.08 [0.84-1.40],0.5468216783076041
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",43183,1204,1.03 [0.89-1.19],0.6868452761959729
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of optic nerve and visual pathways,43305,116,0.89 [0.53-1.50],0.6661510907109014
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of refraction and accommodation,43068,1089,1.05 [0.90-1.22],0.5610333277503181
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of sclera, cornea, iris and ciliary body",43251,611,0.92 [0.73-1.14],0.4338217206989507
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,43166,304,1.01 [0.75-1.36],0.9639670702574118
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ectropion of eyelid,41651,102,0.77 [0.43-1.40],0.393443264520807
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Entropion and trichiasis of eyelid,41661,112,1.21 [0.78-1.90],0.3925759332673891
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Epiphora,41644,95,1.35 [0.88-2.08],0.1651046271737021
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,43168,1180,1.08 [0.93-1.25],0.3047875328563953
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma suspect,42303,315,1.09 [0.82-1.43],0.5583333530399484
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Hypermetropia,42054,75,0.66 [0.32-1.36],0.2547491934501987
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Iridocyclitis,42804,164,1.05 [0.71-1.56],0.8018996939996413
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Keratitis,43100,460,0.89 [0.69-1.16],0.3945948730247663
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Myopia,42309,330,0.92 [0.68-1.24],0.570931371719698
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified disorders of vitreous body,43045,183,0.97 [0.66-1.44],0.8932536244654716
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,42755,767,1.09 [0.91-1.31],0.3294303756756251
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,42434,230,1.06 [0.76-1.48],0.7449384620074113
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,40674,3641,1.09 [1.00-1.18],0.0413127891126629
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of cornea,43042,402,0.84 [0.63-1.12],0.2309149358106557
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eye and adnexa,43282,256,0.89 [0.63-1.27],0.521155673169776
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,42228,679,1.10 [0.91-1.33],0.3481954257613033
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of iris and ciliary body,42752,112,1.13 [0.72-1.78],0.5996999510701739
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of optic [2nd] nerve and visual pathways,43282,93,1.05 [0.62-1.78],0.8478325311977648
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other inflammation of eyelid,41691,142,0.99 [0.63-1.54],0.9525018793373
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,41801,252,1.01 [0.73-1.41],0.9452981112634866
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified retinal disorders,41450,191,1.03 [0.71-1.50],0.872223454392639
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other strabismus,42070,91,1.12 [0.68-1.86],0.6558592263045058
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Other, unspecified and serous retinal detachments",41363,104,0.94 [0.55-1.59],0.8162279782219317
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Primary angle-closure glaucoma,42131,143,1.12 [0.75-1.68],0.569082683747719
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Primary open-angle glaucoma, strict",42312,324,1.02 [0.77-1.37],0.8710408768008413
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ptosis of eyelid,41748,199,0.95 [0.65-1.40],0.807567998385454
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal detachment with retinal break,41440,181,0.81 [0.52-1.24],0.3297454481276869
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal vascular occlusion,41392,133,1.38 [0.97-1.96],0.0776635202186455
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,40005,2972,0.96 [0.87-1.06],0.3732578812436583
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Stenosis and insufficiency of lacrimal passages,41672,123,1.10 [0.71-1.72],0.6647480890697781
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,42887,683,0.91 [0.74-1.13],0.4074024740669402
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,42299,95,0.94 [0.54-1.65],0.8375062652132538
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),42474,270,1.05 [0.77-1.43],0.7569885980808128
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VIII Diseases of the ear and mastoid process,Benign paroxysmal vertigo,42947,149,0.91 [0.58-1.43],0.6874036375972286
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VIII Diseases of the ear and mastoid process,Diseases of external ear,43243,198,1.01 [0.70-1.47],0.9391482947550212
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VIII Diseases of the ear and mastoid process,Diseases of middle ear and mastoid,43102,217,0.86 [0.59-1.27],0.4568547524709553
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VIII Diseases of the ear and mastoid process,Labyrinthitis,42904,106,1.01 [0.61-1.68],0.954435342752318
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VIII Diseases of the ear and mastoid process,M¬éni¬ère disease,42909,111,1.06 [0.65-1.70],0.8237407223487928
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VIII Diseases of the ear and mastoid process,Other disorders of ear,43144,1444,1.03 [0.90-1.18],0.692498317138696
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VIII Diseases of the ear and mastoid process,Other specified/unspecified hearing loss,42737,1037,1.01 [0.86-1.19],0.8762204757230725
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VIII Diseases of the ear and mastoid process,Sensorineural hearing loss,41907,207,1.03 [0.72-1.48],0.8630187627921774
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VIII Diseases of the ear and mastoid process,Tinnitus,41838,138,1.13 [0.75-1.70],0.5731899644496183
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Acute pharyngitis,42898,121,1.06 [0.66-1.68],0.8177713510190705
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,43137,360,0.89 [0.66-1.20],0.4502544369667076
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Acute upper respiratory infections of multiple and unspecified sites,42882,105,0.86 [0.49-1.51],0.592290134318578
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,All influenza,40036,191,0.84 [0.55-1.28],0.4062660560637097
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,All influenza (not pneumonia),40032,187,0.84 [0.55-1.29],0.4235686239361386
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Allergic asthma (mode),29722,198,1.17 [0.84-1.63],0.3658156655945456
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Allergic rhinitis,43108,470,1.01 [0.80-1.29],0.9052290613260956
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",32071,2989,1.05 [0.95-1.15],0.3354048087522877
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",32471,2947,1.05 [0.95-1.15],0.3301468507387127
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Bacterial pneumonia (organism specified),42645,233,1.07 [0.76-1.49],0.7101195550255213
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,"Bacterial pneumonia, not elsewhere classified",39978,133,1.08 [0.69-1.67],0.7484019120347633
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Bronchiectasis,37509,583,1.07 [0.87-1.32],0.5419470057000351
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,"Bronchitis, not specified as acute or chronic",37019,93,0.84 [0.46-1.55],0.5849484397429572
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,41614,4688,1.08 [1.01-1.17],0.0341010128263887
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,"Chronic rhinitis, nasopharyngitis and pharyngitis",41007,124,0.59 [0.33-1.05],0.0730991346833031
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Chronic sinusitis,41137,254,1.18 [0.88-1.59],0.2598681543100929
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",42986,1966,1.12 [1.00-1.25],0.0596392270711661
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Deviated nasal septum,41073,190,0.65 [0.41-1.03],0.0649204645095422
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,39831,8736,1.04 [0.98-1.10],0.2029734154588179
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",41509,626,0.75 [0.59-0.96],0.0214453410993212
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Early onset COPD,41557,537,1.26 [1.01-1.58],0.0379655716368193
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Emphysema,37452,526,1.29 [1.05-1.58],0.0150797462113092
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,41089,492,1.01 [0.80-1.29],0.9147901353390308
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Influenza and pneumonia,42939,3094,1.01 [0.92-1.11],0.796588656167102
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Interstitial lung disease,41143,546,1.04 [0.83-1.30],0.7334522640796748
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Later onset COPD,41613,1429,1.07 [0.93-1.23],0.3381536912670551
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Lung diseases due to external agents,43297,504,0.93 [0.73-1.19],0.583351021178506
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Nasal polyp,41069,186,1.07 [0.74-1.54],0.7320302111900525
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,42887,1589,1.02 [0.90-1.16],0.7390723064941207
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Other diseases of pleura,42924,3297,1.02 [0.93-1.11],0.7197952562996148
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,42292,1409,0.94 [0.81-1.08],0.3729174192508978
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Other pleural conditions,39710,83,1.21 [0.73-2.01],0.4703513132390601
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,43151,680,1.01 [0.83-1.24],0.9061917521384406
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,43138,2159,0.98 [0.88-1.10],0.7737567757357787
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Pleural effusion,41244,1617,1.06 [0.94-1.21],0.3326648988464581
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Pleural plaque,39890,263,1.01 [0.73-1.40],0.948205028072858
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",42519,2674,1.00 [0.90-1.11],0.9671933725806958
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Pneumonitis due to solids and liquids,43186,393,0.98 [0.75-1.28],0.8622319986915001
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Pneumothorax,39832,205,0.94 [0.64-1.37],0.7326217105266641
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Pollen allergy,43279,398,0.91 [0.69-1.20],0.5188816282547153
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Pulmonary oedema,42583,112,1.12 [0.70-1.78],0.6413379802256207
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Respiratory insufficiency,29613,89,1.03 [0.59-1.81],0.9129144627200833
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,42853,1555,1.01 [0.89-1.16],0.8470297606576564
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Vasomotor and allergic rhinitis,41354,471,1.00 [0.79-1.28],0.9831115221294308
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Viral pneumonia,40254,409,1.21 [0.96-1.52],0.1015545066030607
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,"Viral pneumonia (unknown virus, not influenza)",42674,338,1.19 [0.92-1.54],0.1862408889806162
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,20022,179,0.77 [0.50-1.20],0.2528893343810664
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,30688,109,1.19 [0.76-1.88],0.4463041006478643
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Acute appendicitis,43043,242,1.12 [0.81-1.53],0.4980761931566503
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Acute gastritis,32670,142,0.77 [0.46-1.27],0.3048305039488661
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Acute pancreatitis,40237,312,0.86 [0.63-1.19],0.368499925125459
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Acute peritonitis,42540,150,1.38 [0.98-1.93],0.065373852404396
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Alcoholic liver disease,41817,121,1.41 [0.97-2.05],0.0679787617571807
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Barrett oesophagus,33252,724,1.14 [0.95-1.37],0.156423602448295
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC)",40095,170,0.97 [0.65-1.46],0.8914919346321886
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC), with reimbursement 202",42623,170,0.97 [0.64-1.46],0.8750915092311047
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Cholecystitis,40257,332,1.04 [0.78-1.38],0.7958023529965554
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Cholelithiasis,41609,1684,1.04 [0.92-1.18],0.4937195572204673
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Chronic gastritis,33029,501,1.07 [0.85-1.34],0.5799624818467919
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Chronic pancreatitis,40007,82,0.92 [0.50-1.70],0.796648882032138
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,"Cirrhosis of liver, NAS",43081,178,1.10 [0.76-1.60],0.6129277256074277
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Coeliac disease,40633,200,1.03 [0.72-1.48],0.8665230145449749
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Collagenous colitis,40499,136,1.23 [0.84-1.81],0.2882439466363723
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,43050,319,1.13 [0.86-1.49],0.3812941243507335
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Constipation,42899,2723,0.93 [0.84-1.03],0.1831057510900298
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Crohn disease,40509,146,1.19 [0.80-1.75],0.3906310484025159
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",42724,105,1.20 [0.76-1.89],0.430355287706667
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Crohn's disease NAS,40501,138,1.19 [0.80-1.77],0.4030264530084222
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Dental caries,42077,386,1.20 [0.95-1.52],0.1317453578892596
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,38913,3688,1.06 [0.98-1.16],0.1396755964020032
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Diseases of appendix,43107,306,1.20 [0.92-1.56],0.1870064073848804
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Diseases of liver,43120,1424,1.10 [0.97-1.26],0.1390956510994886
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",39681,7153,1.00 [0.94-1.07],0.9221777921346912
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",42618,927,1.12 [0.95-1.31],0.1780904704844851
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Diseases of peritoneum,43175,785,1.19 [1.01-1.41],0.0385013113214625
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,41881,190,1.05 [0.72-1.53],0.7922814012644529
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Diseases of salivary glands,41642,106,1.21 [0.77-1.89],0.4092409980529534
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Diseases of the digestive system,42804,2371,1.06 [0.95-1.17],0.3014457657193964
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Diseases of tongue,41658,184,1.51 [1.14-2.00],0.0036300728943661
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",42288,2363,1.04 [0.93-1.15],0.5229473670563194
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,35872,5293,1.01 [0.94-1.08],0.804518801687896
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Duodenal ulcer,32857,329,0.82 [0.59-1.14],0.2389511458478027
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",43173,261,0.74 [0.50-1.08],0.114212923908118
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,43173,92,0.71 [0.38-1.35],0.2988472553139008
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Fibrosis and cirrhosis of liver,41910,214,1.22 [0.89-1.68],0.2116987988836362
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,30826,247,1.14 [0.84-1.56],0.3879009102719899
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Functional dyspepsia,33448,920,1.00 [0.84-1.19],0.9677527322574614
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Gastric ulcer,33134,606,1.11 [0.90-1.37],0.3135938302932098
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,36681,4153,1.03 [0.95-1.12],0.4598978866466358
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,33427,899,0.98 [0.82-1.18],0.8645419049947751
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,33551,13827,1.01 [0.97-1.06],0.5516701137171727
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,GI-bleeding,42354,1921,1.07 [0.95-1.20],0.2676609186857402
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Gingivitis and periodontal diseases,41795,104,1.24 [0.80-1.92],0.3427723621526948
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Haemorrhoids and perianal venous thrombosis,32181,2082,0.97 [0.87-1.09],0.6542316974254434
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,"Hepatic failure, not elsewhere classified",41798,102,1.37 [0.90-2.09],0.142252583808392
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Hernia,40597,5372,1.03 [0.96-1.10],0.4825605433998956
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Impacted teeth,43184,86,0.75 [0.39-1.42],0.3731018051022063
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Impaction of intestines,30671,92,1.13 [0.68-1.86],0.6351749199980476
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Inguinal hernia,36733,1508,0.97 [0.85-1.11],0.6745350123384648
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,"Inguinal hernia, bilateral",35391,166,1.17 [0.81-1.67],0.4062523669250505
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Intestinal adhesions without obstruction,30741,162,1.22 [0.86-1.74],0.2669465655000448
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Intestinal malabsorption,40671,238,0.97 [0.69-1.36],0.8454293196074327
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,31510,931,0.94 [0.79-1.12],0.4924122751679377
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Nonalcoholic fatty liver disease,43272,611,1.03 [0.83-1.27],0.7775323963521988
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,41624,1261,0.99 [0.85-1.15],0.9138502253647834
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,42038,1675,0.99 [0.87-1.13],0.9292196098702104
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Oesophageal obstruction,32836,308,1.02 [0.75-1.37],0.9108120010669264
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Oesophagitis,33541,1013,1.00 [0.85-1.18],0.9993039230443946
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,43234,229,1.11 [0.80-1.53],0.5334063223699932
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Other and unspecified abdominal hernia,35338,113,0.94 [0.57-1.57],0.8173215788497239
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,32869,2290,1.01 [0.90-1.12],0.9128486096421432
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,40390,465,0.99 [0.77-1.26],0.92835431009912
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Other diseases of gallbladder,40185,260,1.21 [0.91-1.61],0.1857484246310753
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Other diseases of intestine,33508,2929,1.10 [1.01-1.21],0.036659179724914
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Other diseases of intestines,39952,9373,1.01 [0.96-1.07],0.7356795564082623
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,41633,348,1.10 [0.85-1.43],0.4622980656329225
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Other diseases of liver,42857,1161,1.06 [0.91-1.23],0.4639590656084497
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,33636,1108,1.16 [1.00-1.34],0.0510324963873416
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Other diseases of pancreas,40171,246,1.05 [0.76-1.45],0.7796121493277539
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,43065,675,1.16 [0.97-1.39],0.1089942303254411
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,34118,1590,1.01 [0.88-1.15],0.906258013736565
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,42379,1946,1.07 [0.95-1.20],0.2554055014595839
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,41986,295,1.16 [0.88-1.53],0.2810372508676979
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,33381,2802,0.97 [0.88-1.08],0.6060761337977982
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),35852,3324,1.01 [0.92-1.11],0.8062834420448113
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Other inflammatory liver diseases,41863,167,1.29 [0.92-1.81],0.1450377797575858
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,41837,1474,1.00 [0.87-1.15],0.9916937165452056
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",31147,568,1.13 [0.93-1.39],0.2220366994348892
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,43156,109,0.74 [0.42-1.32],0.3083879968116367
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,31394,815,1.12 [0.95-1.33],0.1819492668192633
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",40695,262,1.13 [0.83-1.52],0.4412112173058721
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Recurring oral aphthae,43298,98,0.93 [0.53-1.61],0.7885333578779374
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Stomatitis and related lesions,41699,200,1.04 [0.72-1.49],0.8515784170138023
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Toxic colitis,40453,90,0.72 [0.38-1.37],0.3129137622650622
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,32986,458,1.05 [0.82-1.34],0.7054387189919937
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Ulcerative colitis,40626,263,0.91 [0.65-1.28],0.5977264440566071
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",40581,218,1.00 [0.70-1.42],0.9818548412498012
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Umbilical hernia,35666,441,0.81 [0.61-1.07],0.1412729278401411
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Vascular disorders of the intestines,30873,294,0.90 [0.65-1.25],0.537685412838163
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Ventral hernia,35650,425,1.22 [0.97-1.52],0.0830346581897195
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Volvulus,30712,133,1.09 [0.71-1.68],0.6804847501235576
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Actinic keratosis,43192,476,1.03 [0.81-1.30],0.8273878926740219
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Arthropathic psoriasis,42785,133,0.69 [0.40-1.18],0.1749729503987051
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,39948,273,0.76 [0.53-1.08],0.1262591587878329
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,42241,1165,0.99 [0.85-1.16],0.8946167783970721
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",41372,296,1.08 [0.81-1.46],0.5920016528288761
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Decubitus ulcer and pressure area,40304,629,1.08 [0.88-1.32],0.4547817396980892
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis,42804,461,0.85 [0.65-1.10],0.2199519210956093
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,43142,799,0.92 [0.75-1.11],0.3818931880437498
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis due to substances taken internally,42422,79,0.80 [0.42-1.54],0.5043930260967958
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,40691,5298,0.98 [0.91-1.06],0.628217850119557
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,42549,738,0.97 [0.80-1.18],0.7887485223047392
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,42325,514,1.01 [0.80-1.27],0.9558016584354682
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,42648,1572,0.99 [0.86-1.13],0.8281108320637469
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,"Lichen planus, including avohilmo",43290,91,0.82 [0.45-1.49],0.5108094783176186
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Lupus erythematosus,39784,109,1.29 [0.86-1.95],0.2175953643335058
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,41901,90,1.05 [0.61-1.80],0.8713960553359084
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified dermatitis,42786,443,0.85 [0.64-1.11],0.2276464807781669
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,40431,756,0.89 [0.73-1.09],0.2714847125787222
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified epidermal thickening,39788,113,0.92 [0.55-1.54],0.7445713981753036
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified erythematous conditions,43180,134,0.80 [0.48-1.33],0.392912392510185
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified local infections of skin and subcutaneous tissue,41367,291,0.95 [0.69-1.31],0.7625147522747673
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,42973,321,1.35 [1.07-1.72],0.0121015317133215
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other contact dermatitis,42439,96,0.78 [0.43-1.44],0.4323072632229117
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of pigmentation,39781,106,0.48 [0.25-0.93],0.0292405899505097
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,42351,2676,0.96 [0.87-1.07],0.4630452793240659
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",40499,824,0.90 [0.74-1.09],0.2835365035981379
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other epidermal thickening,39793,118,1.04 [0.65-1.67],0.8696044181410412
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,43170,518,1.14 [0.92-1.41],0.2303079094209627
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Pruritus,42463,120,1.18 [0.77-1.81],0.4485799320268611
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,43076,424,1.20 [0.95-1.50],0.122369510924838
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,43233,517,1.06 [0.85-1.32],0.5857773100889738
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,39892,217,0.73 [0.48-1.10],0.1324796573760842
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,40117,442,1.01 [0.79-1.29],0.9342062779799624
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,43217,501,1.04 [0.83-1.30],0.7642131029017001
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,"Ulcer of lower limb, not elsewhere classified",40047,372,1.10 [0.85-1.43],0.4674765299301983
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Urticaria and erythema,43269,223,0.91 [0.62-1.31],0.5998912181344882
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Adhesive capsulitis of shoulder,37135,183,0.86 [0.56-1.31],0.4829281574871267
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,39418,9402,1.03 [0.98-1.09],0.2532752164749004
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,37079,7063,1.05 [0.99-1.11],0.1293340221949449
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Bursitis of shoulder,37082,130,1.13 [0.74-1.74],0.5699712800839124
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,37592,253,1.20 [0.90-1.61],0.2151741860167385
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,37638,299,0.88 [0.63-1.21],0.4275106444911476
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Chondropathies,42900,151,1.28 [0.89-1.83],0.1801424997777005
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Collapsed vertebra, not elsewhere classified",37506,167,0.65 [0.39-1.06],0.0852598457846154
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,31930,1914,1.02 [0.91-1.15],0.7573020125636288
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",43079,323,0.78 [0.56-1.09],0.1418429946687103
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,38054,715,1.01 [0.84-1.23],0.8800997360075662
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,36605,12117,1.04 [1.00-1.09],0.062936574312198
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,40033,194,0.64 [0.41-1.02],0.0597029940381059
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of muscles,37201,249,1.24 [0.92-1.67],0.1530844236457973
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,37920,968,1.15 [0.99-1.35],0.0683089814765225
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,41747,4408,1.04 [0.97-1.13],0.2887120608899161
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,37420,468,1.07 [0.85-1.36],0.5559550569712266
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibromyalgia,37333,381,1.06 [0.81-1.37],0.6751475592793938
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,37186,234,1.00 [0.71-1.41],0.9892901342516038
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Giant cell arteritis,42201,121,0.96 [0.59-1.55],0.859869307429441
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,32826,2810,1.03 [0.94-1.14],0.5101931236603259
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,30988,972,1.13 [0.97-1.33],0.1106043265780797
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",43193,956,1.11 [0.95-1.31],0.2008539145634026
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,30142,126,0.86 [0.52-1.42],0.5521928708959107
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),30579,563,0.94 [0.75-1.18],0.5851281012376762
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,37464,512,1.30 [1.07-1.58],0.0070791214230424
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,31085,1069,1.06 [0.91-1.24],0.4504256620859546
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Kyphosis,37427,88,1.34 [0.86-2.09],0.1944992628077949
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,38386,1047,0.94 [0.79-1.11],0.4386247592358864
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,37841,502,0.91 [0.71-1.16],0.4312482133006377
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,31012,996,1.11 [0.95-1.29],0.2017897842610906
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Myalgia,37080,128,1.10 [0.70-1.72],0.6886909590598962
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Neuralgia and neuritis, unspecified",37053,101,0.72 [0.39-1.33],0.2952841737697125
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteomyelitis,39954,115,0.98 [0.59-1.62],0.9244233756221688
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,42673,2834,0.99 [0.90-1.09],0.8535660019610849
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,41701,1862,1.01 [0.90-1.14],0.8684237943106665
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",43072,753,1.26 [1.07-1.49],0.0048205094413391
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,34170,4154,1.09 [1.01-1.18],0.0194448512639636
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other articular cartilage disorders,30118,102,0.68 [0.37-1.26],0.2184290016895976
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other bursopathies,37104,152,1.43 [1.03-1.98],0.0303697653843952
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other crystal arthropathies,30107,91,1.39 [0.92-2.11],0.1211349311387345
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),30226,210,1.10 [0.79-1.53],0.5882846946834203
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,40246,407,1.04 [0.81-1.34],0.7556272038502153
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone density and structure,40451,612,1.02 [0.83-1.25],0.8419954175630862
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of the musculoskeletal system and connective tissue,43266,162,1.27 [0.89-1.80],0.1854558497934879
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",40332,2993,1.01 [0.92-1.11],0.8037097180755702
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,37118,166,0.98 [0.65-1.48],0.9148898700407984
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),30250,234,1.07 [0.77-1.47],0.6929442010999596
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,38549,1210,1.03 [0.89-1.19],0.7244949425531824
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,33608,3592,1.01 [0.92-1.10],0.9041989816140544
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other necrotizing vasculopathies,42237,157,1.14 [0.78-1.67],0.5059937508243254
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other psoriatic arthropathies,43288,127,0.59 [0.33-1.05],0.0703100051958269
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,37088,136,1.57 [1.13-2.17],0.0067458340426794
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",39028,2076,1.12 [1.01-1.25],0.0384868496705105
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified disorders of muscle,37096,144,1.28 [0.88-1.87],0.194260743914933
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,32719,2703,1.00 [0.90-1.10],0.9401272586063646
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,40034,195,1.00 [0.69-1.45],0.9931258806152662
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies,37038,86,1.12 [0.67-1.88],0.6635641465438556
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified inflammatory spondylopathies,37604,265,1.14 [0.85-1.53],0.3780932971715556
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,37852,900,1.13 [0.96-1.34],0.1316308962111802
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,42688,608,1.11 [0.91-1.35],0.3047421339933581
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,38294,955,1.03 [0.87-1.21],0.7511508237590087
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,43092,733,1.29 [1.09-1.51],0.0023490610425548
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified seropositive rheumatoid arthritis,43284,90,1.02 [0.59-1.77],0.9336597576884929
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,37272,320,1.41 [1.12-1.76],0.0033311274026163
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,34267,1250,0.92 [0.79-1.08],0.3181676041924152
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,37917,965,1.11 [0.94-1.30],0.2241021014093235
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],37342,390,1.16 [0.91-1.49],0.2294243569677479
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Polyarthritis, unspecified",30112,96,1.21 [0.76-1.92],0.4230991953703796
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,34151,4135,1.06 [0.98-1.14],0.1659801189190441
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,31105,1089,0.99 [0.84-1.16],0.8621867299779273
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polymyalgia rheumatica,42469,389,1.02 [0.78-1.32],0.9058696219055844
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Postprocedural musculoskeletal disorders, not elsewhere classified",43206,102,1.46 [0.99-2.15],0.0594473957797127
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Primary gonarthrosis, bilateral",39710,82,0.77 [0.40-1.49],0.4411211400810252
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Psoriatic arthropathies,30146,130,0.63 [0.36-1.10],0.1050830717435908
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Radiculopathy,37506,167,0.84 [0.54-1.31],0.4403220035038205
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,30779,763,1.25 [1.06-1.46],0.0069589317946861
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,37470,518,1.26 [1.04-1.54],0.0200107724677406
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,37762,423,1.06 [0.83-1.35],0.6601159860830582
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Scoliosis,37643,304,0.99 [0.73-1.33],0.9405048362997804
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Seronegative rheumatoid arthritis,33881,101,1.09 [0.67-1.77],0.7245708025117176
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Seropositive rheumatoid arthritis, wide",43290,96,1.08 [0.65-1.80],0.7741572085148383
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,37942,990,1.14 [0.97-1.33],0.1108643727941165
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sicca syndrome [Sj¬ögren],42242,162,1.26 [0.89-1.77],0.1913565722227833
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,41278,4326,1.10 [1.02-1.19],0.0143322635754795
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",37174,222,0.90 [0.62-1.32],0.5941236401943115
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,38226,887,1.13 [0.96-1.33],0.1365135861264409
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondyloarthritis,40926,388,1.09 [0.85-1.41],0.4930451551258112
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylolisthesis/Spondylolysis,37667,328,1.03 [0.77-1.37],0.844188118623729
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,39901,2562,1.09 [0.99-1.21],0.0729154241921372
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,39011,1672,1.08 [0.96-1.22],0.205038307753968
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Synovial cyst of popliteal space [Baker],37039,87,1.63 [1.12-2.35],0.0098555830932671
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,42321,241,1.03 [0.74-1.43],0.8587614526538732
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,37231,279,1.12 [0.83-1.51],0.4633906846422108
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trochanteric bursitis,37082,130,0.80 [0.48-1.34],0.4027750761296693
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Wrist or foot drop (acquired),30108,92,1.44 [0.95-2.17],0.081845941798371
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Acute renal failure,41760,2508,1.03 [0.93-1.15],0.532756491031227
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Adenomyosis (Endometriosis of uterus),17527,85,1.20 [0.73-1.97],0.4822282307935659
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Benign mammary dysplasia,22857,97,1.21 [0.77-1.92],0.4096315439050322
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,42786,528,1.13 [0.92-1.40],0.2538037152466222
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Calculus of lower urinary tract,42404,146,1.13 [0.75-1.69],0.5660337847671872
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,41510,2258,1.05 [0.95-1.17],0.3319283387685969
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Chronic nephritic syndrome,42986,103,1.52 [1.04-2.21],0.0291645734540491
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Cyst of kidney,42956,482,1.02 [0.81-1.30],0.8505986430157454
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Cystitis,38237,380,0.96 [0.73-1.26],0.7587009555475197
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Dialysis,39360,108,0.87 [0.50-1.51],0.6133558611947643
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Diseases of male genital organs,18818,2749,0.93 [0.84-1.03],0.1682591580676358
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Disorders of breast,23040,280,0.97 [0.71-1.33],0.856559019318887
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Endometriosis,17590,148,1.09 [0.73-1.63],0.6819486509045913
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,"Excessive, frequent and irregular menstruation",17776,334,1.05 [0.80-1.38],0.7078433819531296
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Female genital prolapse,18302,860,1.07 [0.90-1.26],0.4597945112688202
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,36152,8835,0.99 [0.94-1.05],0.7206418164465653
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Glomerular disorders in diseases classified elsewhere,43004,121,1.26 [0.84-1.91],0.2632136177489225
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Hydrocele,16244,175,0.96 [0.64-1.44],0.8562585954926596
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Hydronephrosis,39210,464,1.05 [0.83-1.33],0.6646149730809982
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Hyperplasia of prostate,18218,2149,0.94 [0.84-1.06],0.3100237690660741
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of female pelvic organs,22978,339,1.13 [0.87-1.46],0.370969258914512
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of prostate (prostatitis),16266,197,0.94 [0.64-1.38],0.7487144234400614
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Irregular menses,23056,107,0.74 [0.42-1.30],0.2961774570177643
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Menorrhagia,17705,263,1.11 [0.83-1.49],0.488331659407652
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,37984,127,0.82 [0.49-1.37],0.4546282122760531
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Noninflammatory disorders of female genital tract,19514,2072,1.05 [0.94-1.17],0.3866285425245265
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Orchitis and epididymitis,16168,99,1.28 [0.82-1.98],0.2782281925930348
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Other abnormal uterine and vaginal bleeding,17557,115,0.85 [0.50-1.44],0.5428215766844919
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,"Other chronic cystitis, drug-induced",43304,108,0.73 [0.41-1.32],0.3002675083407398
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,"Other cystitis, drug-induced",43304,106,1.01 [0.61-1.67],0.9791350570151204
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,41559,3702,1.02 [0.94-1.11],0.6119086419268174
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,39062,1205,1.01 [0.87-1.17],0.9205915685902106
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Other disorders of breast,22858,98,0.45 [0.23-0.91],0.0250635298756018
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,43218,744,1.08 [0.90-1.29],0.4336205247402537
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Other disorders of male genital organs,16327,258,0.61 [0.41-0.92],0.0172013250264392
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Other disorders of penis,16306,237,0.71 [0.48-1.06],0.0974132556631718
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Other disorders of prostate,16257,188,0.99 [0.68-1.46],0.9725193274305252
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Other disorders of the genitourinary system,43259,117,0.99 [0.61-1.60],0.9539536429443968
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,40677,2820,1.00 [0.90-1.10],0.9559893700013636
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Other female pelvic inflammatory diseases,22814,175,1.17 [0.83-1.66],0.3775385520321634
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of cervix uteri,17577,135,1.29 [0.88-1.88],0.1905088053078897
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,"Other noninflammatory disorders of uterus, except cervix",17773,331,1.21 [0.94-1.56],0.1365917018268883
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vagina,17539,97,0.77 [0.42-1.42],0.4085804486569337
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vulva and perineum,17616,174,0.97 [0.65-1.46],0.8949592629859675
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,39287,541,1.07 [0.87-1.33],0.5151910343425264
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Other specified disorders of kidney and ureter,42720,246,1.16 [0.86-1.57],0.3290147836240823
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Ovarian cyst,17702,260,1.22 [0.92-1.62],0.1569835723166002
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Pain and other conditions associated with female genital organs and menstrual cycle,17532,90,1.02 [0.58-1.77],0.9575645768058636
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Polyp of the female genital tract,17979,537,1.02 [0.81-1.27],0.8769482435365065
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Postmenopausal atrophic vaginitis,17579,137,1.15 [0.76-1.73],0.5116457075284875
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Postmenopausal bleeding,17937,495,1.01 [0.80-1.27],0.9516969871468473
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Recurrent and persistent haematuria,42970,87,1.12 [0.66-1.90],0.6630873947528658
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,"Redundant prepuce, phimosis and paraphimosis",16289,220,0.83 [0.56-1.23],0.3540866413256954
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,42966,4220,1.01 [0.94-1.10],0.7250694211336247
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,"Tubulo-interstitial nephritis, not specified as acute or chronic",38941,195,1.17 [0.83-1.64],0.3658691436840937
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,39439,187,0.98 [0.67-1.45],0.9315705389954873
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,42352,94,1.13 [0.68-1.89],0.6398378048618583
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Urethral stricture,38231,374,1.21 [0.95-1.53],0.1225422926148035
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Urolithiasis,42921,663,1.15 [0.95-1.38],0.1525470313318163
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Uterine polyps,17560,118,0.93 [0.57-1.53],0.7829198326578884
